BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice Source: International Congress 2016 – Mechanisms of disease Year: 2016
Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
A selective MMP-12 inhibitor, MV062926, reduces inflammatory responses to cigarette smoke in mice Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013
Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013
Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015
Effects of tobacco smoke and poly IC, alone and in combination, on mouse lung pathology Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013
cPLA2alpha plays a role in neutrophilic inflammatory response in mice induced by tobacco smoke exposure Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015
Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013
Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice Source: Eur Respir J 2006; 27: 1102-1109 Year: 2006
Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Cigarette smoke in mice, rats and guinea-pigs: value to the study of pathogenic factors involved in COPD Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005
CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Temporal profile of metaloproteases gene expression in elastase-induced emphysema Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013